Hydrophobic interaction chromatography (HIC) separates biomolecules based on how strongly hydrophobic regions on their surfaces interact with mildly hydrophobic ligands on the chromatography resin. In a high-salt environment, these hydrophobic regions bind to the resin; as the salt concentration is gradually reduced, molecules elute according to differences in surface hydrophobicity. For pharmaceutical researchers, biologics development teams, purification scientists, and CMC project managers, HIC offers orthogonal selectivity for monoclonal antibodies, antibody conjugates, recombinant proteins, enzymes, peptides, fusion proteins, and hydrophobic product-related variants. BOC Sciences provides comprehensive HIC Chromatography Services covering method scouting, ligand and salt screening, analytical HIC-HPLC characterization, preparative fractionation, aggregate reduction, hydrophobic variant mapping, and process-ready purification support. By integrating chromatography testing, biomolecule-focused method development, and downstream purification expertise, we help clients convert difficult hydrophobicity-driven separation problems into reliable, data-supported workflows.
We develop customized HIC methods based on your molecule's surface hydrophobicity, solubility behavior, salt tolerance, and target separation goal. Our scientists screen resin chemistry, ligand density, salt type, salt concentration, gradient profile, pH, temperature, and loading conditions to establish a robust method for analytical or purification use.
BOC Sciences applies analytical HIC to characterize hydrophobic variants, product-related species, antibody conjugate distributions, aggregate-prone populations, and batch-to-batch hydrophobicity shifts. Our HPLC testing platform supports high-resolution separation, peak integration, fraction tracking, and orthogonal comparison with other chromatographic methods.
For clients requiring isolated hydrophobic variants, enriched monomer fractions, purified conjugate populations, or recovered active protein, we provide preparative and semi-preparative HIC purification. Our team combines HIC with custom purification services to improve recovery, maintain molecular integrity, and generate usable fractions for downstream evaluation.
HIC performance can be highly sensitive to salt composition, sample conductivity, protein concentration, ligand strength, and hold conditions. BOC Sciences helps clients diagnose broad peaks, irreversible binding, low recovery, co-elution, sample precipitation, and unexpected hydrophobic variant shifts through a structured troubleshooting program.
BOC Sciences delivers tailored HIC chromatography solutions for biologics, peptides, protein conjugates, enzymes, and hydrophobic product-related species.
We screen hydrophobic interaction media with varied ligand chemistries and matrix properties to identify the best selectivity window for your molecule, whether the goal is monomer enrichment, variant separation, conjugate fractionation, or impurity reduction.
Our scientists evaluate salt type, salt strength, conductivity, pH, and additive effects to tune hydrophobic binding and elution. This enables precise control over weakly retained species, strongly hydrophobic variants, and late-eluting aggregates.
High-resolution analytical HIC can be configured on HPLC or UHPLC testing systems to support rapid hydrophobicity profiling, peak tracking, method comparison, and sample-limited biomolecule characterization.
HIC data can be combined with SEC, IEX, RP-LC, and 2D chromatography testing to confirm whether separation is driven by hydrophobicity, charge, size, or multiple interacting properties.
Because HIC depends strongly on mobile-phase composition, we establish practical buffer systems and conductivity windows. When needed, salt-related profiling can be supported by ion chromatography testing for deeper process understanding.
Collected HIC fractions can be further evaluated by mass analysis, peptide mapping, activity-related assays, impurity profiling, or orthogonal LC methods to determine which peaks represent desired product, aggregates, variants, or conjugate subpopulations.
BOC Sciences provides HIC method development, characterization, and purification services for a wide range of hydrophobicity-sensitive biomolecules. Our broader analysis and purification capability allows HIC to be integrated into multi-step workflows for challenging biologics, peptides, conjugates, and related compounds.
Share your target molecule, sample matrix, current chromatogram, or purification challenge. Our chromatography team will design a tailored HIC strategy focused on selectivity, recovery, resolution, and downstream usability.
We review the sample type, molecular format, formulation buffer, hydrophobicity-related concerns, target separation objective, available analytical data, and expected output. This step defines whether HIC should be used for characterization, purification, polishing, or troubleshooting.
We screen hydrophobic ligands, salt systems, pH ranges, gradient slopes, loading amounts, and column formats. Early scouting is supported by analytical readouts so that promising conditions can be selected based on resolution, recovery, peak shape, and sample stability.
The selected method is refined through gradient adjustment, conductivity control, repeat injections, and targeted fraction collection. Fractions can be checked by orthogonal methods, including impurity isolation and identification, to confirm the identity and relevance of separated peaks.
We deliver chromatograms, optimized method parameters, fraction data, recovery summaries, and practical recommendations for continued development. For larger purification needs, we can align the HIC method with large scale separation planning.
Aggregates often display stronger hydrophobic retention than the desired monomer, but resolution can be limited when salt gradients are poorly matched to the molecule. BOC Sciences optimizes ligand chemistry, loading conductivity, column residence time, and elution slope to enhance monomer-aggregate separation while reducing unnecessary sample exposure to extreme salt conditions.
Strongly hydrophobic proteins, lipidated peptides, and over-conjugated species may bind too tightly to HIC media. We address this by screening milder ligands, mixed-salt systems, controlled organic modifiers, temperature conditions, and elution additives to recover valuable material without sacrificing the hydrophobic selectivity that makes HIC useful.
Hydrophobic variants may differ only slightly in exposed hydrophobic patches, conjugation level, oxidation state, or folded conformation. Our team combines HIC with impurity profiling, orthogonal LC, and fraction-level characterization to distinguish meaningful product-related species from process-related background peaks.
HIC loading conditions can create precipitation risk for unstable or concentration-sensitive proteins. We evaluate sample dilution, stepwise conductivity adjustment, buffer exchange, pH tuning, and alternative salt selection to maintain solubility while preserving sufficient hydrophobic interaction for the intended separation.
Collaborate with BOC Sciences to develop, optimize, and apply HIC chromatography methods for proteins, antibodies, peptides, enzymes, conjugates, and hydrophobic variants. We help transform complex chromatograms into actionable purification and characterization strategies.
We do not apply a generic chromatography recipe. Each HIC method is built around the molecule's hydrophobicity, stability, salt tolerance, expected variants, and downstream purpose, enabling scientifically justified method decisions.
HIC can reveal hydrophobicity-driven differences that may be hidden in SEC, IEX, or reversed-phase methods. Our integrated platform helps clients understand whether a peak represents aggregation, conjugation, folding, or process-related impurities.
From small analytical samples to preparative fractions, we focus on usable deliverables: optimized methods, fraction pools, chromatographic evidence, recovery data, and clear recommendations for the next development step.
Our scientists understand the behavior of antibodies, fusion proteins, conjugates, enzymes, and hydrophobic peptides, allowing HIC conditions to be adapted to complex structures rather than forcing sensitive molecules into unsuitable workflows.
Client Needs: A biologics research team needed to reduce hydrophobic high-molecular-weight species in a recombinant IgG-like antibody after affinity capture and ion-exchange polishing. SEC showed aggregate presence, but the client needed an orthogonal purification route with improved fraction usability.
Challenges: The antibody showed partial precipitation at high salt concentration, and the aggregate peak overlapped with late-eluting monomer shoulders under the client's initial phenyl-based HIC condition.
Solution: BOC Sciences screened four HIC ligands, three salt systems, and two pH windows, then selected a milder butyl ligand with a shallow decreasing-salt gradient. We performed 18 analytical runs to map retention behavior, collected six fraction windows, and verified monomer enrichment by orthogonal SEC-HPLC and intact mass checks.
Outcome: The optimized HIC method generated a clearly resolved monomer pool with improved recovery and reduced aggregate contribution, giving the client a practical polishing strategy for continued process development.
Client Needs: A project team developing a cysteine-linked antibody conjugate required separation of drug-loaded species to understand distribution across low-, medium-, and high-hydrophobicity populations. Their existing reversed-phase method produced partial denaturation and unclear peak assignment.
Challenges: The conjugated antibody had broad hydrophobic heterogeneity, and strongly loaded species eluted late with partial peak tailing. The client also needed fraction-level confirmation to connect chromatographic peaks with conjugation level.
Solution: BOC Sciences developed a non-denaturing HIC-HPLC method using controlled ammonium sulfate loading, a phenyl-based stationary phase, and a segmented salt gradient. We compared 12 gradient profiles, collected individual DAR-enriched fractions, and cross-checked selected fractions through intact protein mass analysis and antibody conjugation knowledge-based interpretation.
Outcome: The method separated major drug-load populations with improved peak definition, enabling the client to compare conjugation batches and select the most suitable reaction conditions for further development.
Client Needs: A peptide research group required recovery of a lipidated cyclic peptide from a crude reaction mixture containing non-lipidated peptide, over-modified peptide, and hydrophobic synthesis byproducts.
Challenges: The target peptide showed strong retention on reversed-phase media and poor recovery after organic-rich elution. Standard ion-exchange conditions did not separate lipidated and over-modified species effectively.
Solution: We built a HIC-based enrichment workflow using stepwise conductivity adjustment, a short phenyl column, and controlled additive screening to prevent irreversible adsorption. BOC Sciences performed 22 scouting injections, isolated eight pooled fractions, and characterized the target-enriched pools by LC-MS and organic impurities analysis.
Outcome: The optimized workflow improved target peptide recovery, separated the major over-modified impurity, and provided a scalable purification concept for the client's next synthesis campaign.
HIC chromatography is well suited for proteins, antibodies, antibody fragments, fusion proteins, enzymes, peptides, and other biomolecules that show meaningful differences in surface hydrophobicity. It is especially useful when the target molecule must be separated from hydrophobic variants, aggregates, misfolded species, or closely related impurities under relatively mild conditions. BOC Sciences develops customized HIC methods based on sample composition, molecular stability, impurity profile, salt tolerance, and downstream application requirements, helping clients obtain cleaner target fractions while maintaining functional integrity.
Protein aggregates often expose larger hydrophobic regions than properly folded monomers, which can lead to different retention behavior on HIC resins. By optimizing salt concentration, pH, ligand type, column loading, flow rate, and elution gradient, HIC can separate monomeric proteins from aggregates, conformational variants, and other hydrophobic impurities. BOC Sciences evaluates aggregate levels, protein stability, conductivity, and recovery behavior before designing either bind-elute or flow-through strategies, enabling efficient aggregate reduction while preserving the desired protein fraction for further characterization or downstream purification.
HIC method development usually requires systematic optimization of salt type, salt concentration, buffer pH, conductivity, temperature, resin hydrophobicity, ligand chemistry, sample loading, flow rate, gradient profile, and fraction collection windows. Because hydrophobic interactions are typically strengthened under high-salt conditions and weakened as salt concentration decreases, gradient design is critical for resolution and recovery. BOC Sciences uses resin screening, small-scale scouting, gradient comparison, and analytical fraction evaluation to identify conditions that improve target purity, impurity clearance, peak shape, and process compatibility.
HIC separates molecules mainly according to surface hydrophobicity, while ion exchange chromatography separates molecules according to charge properties. This makes HIC highly valuable when the target molecule and impurities have similar charge profiles but differ in hydrophobicity, folding state, aggregation tendency, or surface exposure of hydrophobic patches. In many purification workflows, HIC provides complementary selectivity to affinity chromatography, ion exchange chromatography, and size exclusion chromatography. BOC Sciences selects the appropriate chromatographic combination based on impurity type, molecular behavior, recovery goals, and the required quality of the purified biomolecule.
BOC Sciences provides comprehensive HIC chromatography services for drug discovery, protein engineering, biologics research, and biomolecular purification projects. Our service scope includes sample feasibility assessment, resin and ligand screening, buffer system development, bind-elute and flow-through mode comparison, aggregate removal strategy design, method optimization, scale-up guidance, and data interpretation. Typical deliverables include optimized chromatographic conditions, chromatograms, fraction collection recommendations, impurity reduction results, and technical suggestions for integration with upstream or downstream purification steps, helping clients establish reliable and purpose-driven HIC workflows.
Our antibody variant profile was difficult to interpret with charge-based methods alone. BOC Sciences developed a HIC method that separated the hydrophobic species clearly and gave our team a much stronger basis for process decisions.
— Senior Scientist, Biologics Development
Their HIC-HPLC work helped us understand the distribution of our antibody conjugate populations without forcing the molecule into harsh conditions. The fraction-level interpretation was especially useful for optimizing our conjugation workflow.
— Dr. M. Keller, ADC Project Lead
We had persistent low recovery from a hydrophobic peptide purification. BOC Sciences quickly identified the binding issue, redesigned the salt and additive strategy, and produced a method that recovered material we could actually use.
— Peptide Chemistry Director
The BOC Sciences team understood both analytical HIC and preparative fractionation. Their report connected chromatographic behavior with molecule-specific hydrophobicity, which helped us move from unexplained peaks to a workable purification plan.
— Dr. Elena R., Protein Purification Scientist
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
